Serum organochlorine pesticide residues and risk of testicular germ cell carcinoma: a population-based case-control study.

Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology
Mary L BiggsStephen M Schwartz

Abstract

Testicular germ cell carcinoma (TGCC) is the most common malignancy among men ages 20 to 34 years. Although the pathogenesis of TGCC is poorly understood, suboptimal androgen levels or impaired androgen signaling may play a role. Some persistent organochlorine pesticides commonly found in human tissue possess antiandrogenic properties. We examined whether the risk of TGCC is associated with serum levels of 11 organochlorine pesticides, including p,p'-DDE, and whether the p,p'-DDE-TGCC association is modified by CAG or GGN repeat polymorphisms in the androgen receptor gene. We conducted a population-based case-control study among 18- to 44-year-old male residents of three Washington State counties. Cases (n = 246) were diagnosed during 1999 to 2003 with a first, primary TGCC. Controls (n = 630) were men of similar age with no history of TGCC from the same population identified through random-digit telephone dialing. Questionnaires elicited information on demographic, medical, and lifestyle factors. A blood specimen provided serum for gas chromatography-high-resolution mass spectrometry analysis of organochlorine pesticide residues and DNA for genotyping. We observed no clear patterns between TGCC risk and concentrations of any o...Continue Reading

References

Jul 1, 1989·Archives of Environmental Contamination and Toxicology·D L PhillipsL L Needham
Oct 16, 1989·Clinica Chimica Acta; International Journal of Clinical Chemistry·J R AkinsJ T Bernert
Jun 1, 1986·International Journal of Epidemiology·L M BrownJ T Flannery
Dec 1, 1984·American Journal of Epidemiology·P HartgeJ Waksberg
Jun 5, 1996·Journal of the National Cancer Institute·R BergströmT Hakulinen
Nov 26, 1998·Reviews of Reproduction·E L YongS C Ng
Jul 10, 1999·American Journal of Epidemiology·N D Pharris-CiurejN S Weiss
Mar 4, 2000·Toxicological Sciences : an Official Journal of the Society of Toxicology·T J Schrader, G M Cooke
May 2, 2000·Toxicological Sciences : an Official Journal of the Society of Toxicology·C J WolfL E Gray
Mar 9, 2002·Toxicology and Applied Pharmacology·Helle Raun AndersenEva Cecilie Bonefeld-Jørgensen
Mar 22, 2002·Toxicology and Applied Pharmacology·Cheryl L PortigalColleen C Nelson
Nov 20, 2002·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·C CharlierG Plomteux
Dec 20, 2002·Cancer·Katherine A McGlynnRobert E Tarone
Jan 1, 2003·Reproductive Toxicology·Timothy J Schrader, Gerard M Cooke
Apr 5, 2003·Environmental Health Perspectives·Jody L RalphColleen C Nelson
Jul 31, 2003·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·John R BarrDonald G Patterson
Feb 3, 2004·Environmental Health Perspectives·Gary GinsbergBabasaheb Sonawane
Apr 17, 2004·BJU International·C AsklundN E Skakkebaek
Dec 8, 2004·Environmental Health Perspectives·Jay H LubinPatricia Hartge
Feb 11, 2005·International Journal of Cancer. Journal International Du Cancer·Mark P PurdueKatherine A McGlynn
Jan 6, 2006·International Journal of Cancer. Journal International Du Cancer·Freddie BrayHenrik Møller
Mar 30, 2006·Environmental Science & Technology·Daniel CarrizoMaties Torrent
Oct 4, 2006·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·J SunyerJ O Grimalt

❮ Previous
Next ❯

Citations

Apr 18, 2012·Nature Reviews. Urology·Katherine A McGlynn, Britton Trabert
Oct 7, 2011·Environmental Health Perspectives·Britton TrabertKatherine A McGlynn
Mar 1, 2012·PloS One·Marianna MarangiAnnunziata Giangaspero
Nov 12, 2009·Future Oncology·Katherine A McGlynn, Michael B Cook
Dec 19, 2009·Environmental Health Perspectives·Mark P PurdueKatherine A McGlynn
Aug 14, 2010·Archives of Environmental & Occupational Health·Barbara A CohnRoberta E Christianson
Mar 6, 2012·Urologic Oncology·Joshua J MeeksScott E Eggener
Jun 15, 2011·International Journal of Andrology·M B CookK A McGlynn
Oct 1, 2015·International Journal of Endocrinology·Giacomo TirabassiGiancarlo Balercia
Mar 17, 2015·Journal of Endocrinological Investigation·D PaoliL Gandini
Jun 14, 2014·Frontiers in Public Health·Hueiwang Anna Jeng
Nov 13, 2017·Pharmacological Reports : PR·Beata Starek-ŚwiechowiczAndrzej Starek
Oct 3, 2018·Frontiers in Endocrinology·Donatella PaoliFrancesco Lombardo
Jan 29, 2021·Environmental Research·Dana Boyd BarrElaine M Faustman
Jul 17, 2021·The Journal of Clinical Endocrinology and Metabolism·Elvira V BräunerAnders Juul

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.